Skip to content
10-Q

Quarterly Report

UTAH MEDICAL PRODUCTS INC UTMD

0001811884-24-000022

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 11, 2024 3.39M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $88.45M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $92.87M
Stockholders Equity Q3 2024 · Sep 30, 2024 $124.2M
Stockholders Equity Q3 2024 · Dec 31, 2023 $128.31M
Current Liabilities Q3 2024 · Sep 30, 2024 $3.44M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.71M
Total Liabilities Q3 2024 · Sep 30, 2024 $5.5M
Total Liabilities Q3 2024 · Dec 31, 2023 $7.15M
Current Assets Q3 2024 · Sep 30, 2024 $101.66M
Current Assets Q3 2024 · Dec 31, 2023 $106.27M
Total Assets Q3 2024 · Sep 30, 2024 $129.69M
Total Assets Q3 2024 · Dec 31, 2023 $135.46M
Shares Diluted Q3 2024 · Sep 30, 2023 3.64M sh
Shares Diluted Q3 2024 · Sep 30, 2023 3.64M sh
Stock Repurchased Q3 2024 · Sep 30, 2023 $0
Dividends Paid Q3 2024 · Sep 30, 2023 $3.21M
Capex Q3 2024 · Sep 30, 2023 $549K
Operating Cash Flow Q3 2024 · Sep 30, 2023 $16.95M
Eps Diluted Q3 2024 · Sep 30, 2023 $1.08
Eps Diluted Q3 2024 · Sep 30, 2023 $3.39
Eps Basic Q3 2024 · Sep 30, 2023 $1.08
Eps Basic Q3 2024 · Sep 30, 2023 $3.40
Sga Expense Q3 2024 · Sep 30, 2023 $3.25M
Sga Expense Q3 2024 · Sep 30, 2023 $9.69M
Rd Expense Q3 2024 · Sep 30, 2023 $138K
Rd Expense Q3 2024 · Sep 30, 2023 $414K
Net Income Q3 2024 · Sep 30, 2023 $3.94M
Net Income Q3 2024 · Sep 30, 2023 $12.35M
Operating Income Q3 2024 · Sep 30, 2023 $3.97M
Operating Income Q3 2024 · Sep 30, 2023 $12.83M
Gross Profit Q3 2024 · Sep 30, 2023 $7.36M
Gross Profit Q3 2024 · Sep 30, 2023 $22.94M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $5.15M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $14.95M
Revenue Q3 2024 · Sep 30, 2023 $12.51M
Revenue Q3 2024 · Sep 30, 2023 $37.89M